Procaps Group, S.A. (PROC) News
Filter PROC News Items
PROC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PROC News Highlights
- For PROC, its 30 day story count is now at 2.
- Over the past 5 days, the trend for PROC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest PROC News From Around the Web
Below are the latest news stories about PROCAPS GROUP SA that investors may wish to consider to help them evaluate PROC as an investment opportunity.
PROC Stock Earnings: Procaps Gr Beats EPS, Beats Revenue for Q3 2023PROC stock results show that Procaps Gr beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023. |
Procaps Group Reports Third Quarter 2023 ResultsMIAMI & BARRANQUILLA, Colombia, December 26, 2023--Procaps Group Reports Third Quarter 2023 Results |
Statement from the Board of Directors of Procaps GroupMIAMI & BARRANQUILLA, Colombia, December 21, 2023--Statement from the Board of Directors of Procaps Group |
Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin AmericaProcaps Group (NASDAQ: PROC) ("Procaps"), a leading integrated international healthcare and pharmaceutical services company, and Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB; "Genomma"), the leading pharmaceutical and personal care company in Latin America, today announced a strategic agreement to develop, manufacture and market five Softgel products within Latin America. Through the partnership, Procaps will manufacture and Genomma will market and distribute the products. |
Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024MIAMI & BARRANQUILLA, Colombia, November 22, 2023--Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024 |
Procaps Group Update on Third Quarter ResultsMIAMI & BARRANQUILLA, Colombia, November 14, 2023--Procaps Group Update on Third Quarter Results |
Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023MIAMI & BARRANQUILLA, Colombia, November 10, 2023--Procaps Group to Report Third Quarter and Nine Months Results on Tuesday November 14 and Host Conference Call on Thursday November 16 at 10:30a.m. ET |
Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in ColombiaMIAMI & BARRANQUILLA, Colombia, October 30, 2023--Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia |
Procaps Appoints Sandra Sánchez y Oldenhage to Board of DirectorsMIAMI & BARRANQUILLA, Colombia, October 23, 2023--Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors |
Procaps Group to Participate at CPHI Barcelona 2023MIAMI & BARRANQUILLA, Colombia, October 16, 2023--Procaps Group (NASDAQ: PROC) ("Procaps"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that it will participate at the CPHI Barcelona 2023, that will take place from October 24th to October 26th, continuing with our two-decade presence in the conference. |